Real-time enrollment status for this gm1 gangliosidosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT07082543 |
| Recruiting Status | Recruiting |
| Condition | GM1 Gangliosidosis |
| Phase | Clinical Trial |
| Target Enrollment | 75 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Azafaros A.G. |
| Last Updated on CT.gov | February 9, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT07082543 is currently recruiting participants. This clinical trial study for gm1 gangliosidosis is actively seeking new participants at 3 locations across the United States. The study is sponsored by Azafaros A.G.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07082543 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07082543 was last updated 3 weeks ago (February 9, 2026). HelloStudys verifies this status automatically.